Quality Risk Management in the FDA-Regulated Industry
Intro -- Title Page -- CIP Data Page -- Table of Contents -- List of Figures and Tables -- Acronyms -- Preface to the Second Edition -- Preface to the First Edition -- Acknowledgments -- Chapter 1: Introduction to Quality Risk Management -- 1.1 What Is Quality Risk Management? -- 1.2 Taste of Raspberries, Taste of Death: The 1937 Elixir Sulfanilamide Incident -- 1.3 Seventy Years Later -- 1.4 Risk Management and Risk Assessment -- 1.5 Risk-Based Approach -- FDA's Strategic Action Plan -- Risk-Based Model for Inspectional Oversight -- Part 11 Guidance -- Aseptic Processing Guidance -- 1.6 More than Safety Risks: From Safety Risks to Quality by Design (QBD) -- Medication Guides -- Quality by Design -- Design Controls for Medical Devices -- 1.7 ISO 31000 -- Scope -- 1.8 Historical Perspective and Current Situation -- 1.9 ISO 9001:2015 Risk Requirements -- Risk Management and Preventive Actions -- Chapter 2: Current Initiatives -- 2.1 FDA-Wide -- 2.2 Drugs and Biotechnology Products -- 2.2.1 ICH Q9 -- 2.2.2 QbD Guidances -- 2.2.3 REMS and Medication Guides -- 2.3 Medical Devices -- 2.3.1 ISO 13485:2016 Risk Requirements -- 2.3.2 ISO 14971:2007 -- 2.3.3 GHTF/IMDRF Guidelines -- 2.3.4 Non-U.S. Regulations -- 2.4 Food Safety -- 2.4.1 ISO 22000:2005 and Hazard Analysis and Critical Control Points (HACCP) -- 2.4.2 FDA Food Safety Modernization Act (FSMA): Risk-Based Food Safety Prevention -- 2.5 Supply Chain: Risk Consideration forRegulated Products -- Chapter 3: Principles of Quality Risk Management -- 3.1 Basic Principles -- Continual Improvement -- Full Accountability for Risks -- Application of Risk Managementin All Decision Making -- Continual Communications -- Full Integration into the Organization's Governance Structure -- 3.2 Science and Risk-Based Approach to Product Quality -- 3.3 Quality Systems Approach.